Norelgestromin/Ethinyl Estradiol
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Norelgestromin/Ethinyl Estradiol, covering 2011-07-01 to 2011-07-01. Get the full timeline:
Most recent: Clinical Trial Update: An Open-Label Study to Compare the Bleeding Profile of Norelgestromin/Ethinyl Estradiol in an Extended Regimen to Norelgestromin/Ethinyl Estradiol Given in a Traditional Regimen [Phase 2]